Europe backs new dual-action Novartis lung drug

Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro Breezhaler.

http://www.reuters.com/article/2013/07/26/us-pharmaceuticals-europe-idUSBRE96P0GB20130726?feedType=RSS&feedName=healthNews